Smsbiotech Inc. has gained clearance in Australia to begin a phase I trial of its small mobile stem (SMS) cell therapy for chronic obstructive pulmonary disease (COPD).
The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from angina, ...
The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant ...
Mayo Clinic researchers have identified a molecular "switch" in lung cells that helps them decide when to repair tissue and ...
Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...
Asianet Newsable on MSN
Scientists Reveal Lung Self-Healing Switch, Offering Hope for Chronic Lung Disease
Scientists uncover a molecular “switch” in lung cells that controls repair vs. defense. Targeting it could boost tissue ...
The brain's mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail. Now, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback